Physician profile
Daniel A S Hoffman
NPI 1437133394
$7,357.79
in general payments reported to CMS, 2019-2025
45 companies · $1,759 in 2025
The $1,759 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,071 · 2020: $231 · 2021: $772 · 2022: $634 · 2023: $1,474 · 2024: $1,417 · 2025: $1,759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,500 · Honoraria: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,500.06 |
| Honoraria | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $913.13 | 2021-2025 | |
| Pfizer INC. | $889.26 | 2020-2025 | |
| Amgen INC. | $885.53 | 2019-2025 | Repatha, Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $661.51 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $521.85 | 2019-2024 | Xifaxan, Trulance |
| Lilly USA, LLC | $465.99 | 2019-2025 | Zepbound, Mounjaro, Kisunla |
| Astrazeneca Pharmaceuticals LP | $354.25 | 2019-2025 | Breztri, Airsupra |
| Sk Life Science, INC. | $253.79 | 2024-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $240.03 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $219.65 | 2020-2021 | |
| Daiichi Sankyo INC. | $205.58 | 2019-2023 | Injectafer |
| Axonics, INC. | $150.00 | 2023 | Axonics |
| Ironwood Pharmaceuticals, INC | $126.02 | 2023 | Linzess |
| Neurelis, INC. | $123.67 | 2024-2025 | Valtoco |
| Exact Sciences Corporation | $101.22 | 2023-2025 | Cologuard Collection Kit |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.